期刊文献+

质粒介导的AmpC β-内酰胺酶的研究进展 被引量:5

下载PDF
导出
摘要 质粒介导的AmpCβ-内酰胺酶是近年来发现的一种新型β-内酰胺酶。革蓝阴性杆菌中质粒介导的AmpC酶引起的耐药,因其耐药范围扩大、耐药性由质粒转移、发生率快速增长及新基因型的不断发现,已成为严重的公共卫生问题,引起临床高度重视。大多数质粒介导的AmpCβ-内酰胺酶是非诱导表达,其耐药基因在质粒与染色体间及质粒间转移可能是通过质粒、转座子、整合子等多种途径实现。
作者 蒙杰 赵虎
出处 《南通大学学报(医学版)》 2008年第4期312-314,共3页 Journal of Nantong University(Medical sciences)
  • 相关文献

参考文献15

  • 1刘晶,多丽波.染色体介导的AmpC酶研究进展[J].国际检验医学杂志,2006,27(7):641-643. 被引量:13
  • 2[2]Philippon A,ABet G,Jaeoby GA.Plasmid-determined AmpC-lype Bela-laelamases[J].Anlimierob Agenls Chemolher.2002,46 (1):1-11.
  • 3[4]Fonineau N,Poirel L,Nordmann P.Plasmid-mediated and inducible cephalo8pOrina8e DHA-2 from Klebsiella pneumoniae[J].Antimicrob Chemother,2001,47 (2):207-210.
  • 4[5]Fotfineau N,Naas T,Nordmann P,等.SHV-type extended-spectrum beta-laetamase in a Shigella flexneri clinical isolate[J].Antimicrob Chemother,2001,47 (5):685-688.
  • 5[6]Literaeka E,Empel J.Four variants of the Citrobactar freundii AmpC-type eephalosporinases.including novel enzymes CMY-14 and CMY-15.in a Proteus mirabilis clone widespread in Pol and[J].Antimicrob Agents Chemother 2004,48 (11):4136-4143.
  • 6[7]Nakano R,Okamoto R,Nakano Y,et al.CFE-1,a novel plasmid-encoded AmpC beta-lactamases with an ampR gene originating from Citrobacter freundii[J].Antimicrob Agents Chemother,2004,48 (4):1151-1158.
  • 7余方友.质粒介导的Amp C酶研究进展[J].中华检验医学杂志,2003,26(11):706-709. 被引量:26
  • 8[9]Philippon A,Arlet G,Jacoby GA,et al.Plasmld-Determined Am.pC.Type-Lactamases[J].Antimlcrob Agents Chemother,2002.46 (1):1-11.
  • 9[10]Fortlneau N,Poirel L,Nordmann P.Plasmid-mediated and in-ducible cephalosporinase DHA -2 from Klebsiella pneumoniae[J].Antimicrob Chemother,2001,47 (2):207-210
  • 10[11]Bauernfeind A,Schneider I,Jungwirth R,et al.A novel type of AmpC beta-lactamase,ACC-1,produced by a Klebsiella pneumoni-ae strain causing nosoeomlal pneumonia[J].Anfimicrob Agents Chemother,1999,43 (8):1924-1931.

二级参考文献34

  • 1周强,徐元宏.AmpCβ-内酰胺酶的产生机制及检测方法学进展[J].国外医药(抗生素分册),2004,25(4):176-180. 被引量:9
  • 2Lorian V eds. Antibiotics in laboratory medicine [M], 4^th ed. Baltimore: Williams & Wilkins,1996.
  • 3Medeiros A A. Evolution and dissemination of β-1actamases accelerated by generations of β-lactam antibiotics [J]. Clin Inject Dis, 1997.24 : S 19.
  • 4Jones R N. Important and emerging β-lactamase-mediated resistance in hospital-based pathogens:the AmpC enzymes [J]. Diagn Microbiol Inject Dis, 1998.31 : 461.
  • 5Livemore D M. Clinical significance of beta-lactamase induction and stable derepression in Gram-negative rods [J]. Eur J Clin Microbiol, 1987.6 : 439.
  • 6Bush K, Jacoby G A, Medeiros A A. A functional classification scheme for beta-lactamasess and its correlation with molecular structure [J]. Antimicrob Agents Chemother, 1995,39:1211.
  • 7Coudron P E, Moland E S, Thomson K S. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center [J]. J Clin Microbiol, 2000, 38;1791.
  • 8National Committee for Clinical Laboratory Standards.Performance standards for antimlcroblal susceptibility test-ing; 11'h informational supplement (M100-Sll) [S~.Wayne : NCCLS, 2001.
  • 9Sakurai Y, Yoshida Y, Saitoh K. et al. Characteristics of aztreonam as a substrate, inhibitor and inducer for β-lactamases [J]. J Antibiot, 1990,43:403.
  • 10Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extencle-speetrum -lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes [J]. J Clin Microbiol, 2000,38 : 542.

共引文献62

同被引文献53

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部